Global Ophthalmology Diagnostics and Surgical Devices Market Reaches USD 63,273.2 Mn in 2026, Driven by Rising Prevalence of Eye Disorders and an Expanding Geriatric Population

Technological Advancements in Ophthalmic Diagnostics and Minimally Invasive Surgical Devices to Drive Global Ophthalmology Diagnostics and Surgical Devices Market to USD 98,950.1 Mn by 2033 at 6.8% CAGR – Coherent Market Insights

Ophthalmology refers to a branch of medicine that deals with the detailed study of structure, function and disorder of the eyes. Ophthalmologists, optometrists and opticians are professionals involved in the diagnosis and treatment of several eye ailments ranging from minor vision defects (myopia, hyperopia, astigmatism, etc.) to chronic eye disorders (diabetic retinopathy, macular degeneration, retinitis pigmentosa, etc.).

The global ophthalmology diagnostics and surgical devices market is estimated to account for USD 63,273.2 Mn in terms of value in 2026 and is expected to reach USD 98,950.1 Mn by the end of 2033.

Global Ophthalmology Diagnostics and Surgical Devices Market: Drivers

Approval and launch of products is expected to propel growth of the global ophthalmology diagnostics and surgical devices market over the forecast period. For instance, in May 2026, Carl Zeiss Meditec announced that Mexico’s COFEPRIS approved the ZEISS ARTEVO 850 ophthalmic surgical microscope and ZEISS MICOR 700 lens-removal device. These systems provide advanced 3D surgical visualization, integrated digital workflows, and handheld ultrasound-free lens extraction, supporting improved efficiency and precision in cataract procedures.

Global Ophthalmology Diagnostics and Surgical Devices Market: Opportunities

Increasing prevalence of diabetes is expected to offer lucrative growth opportunities for players in the global ophthalmology diagnostics and surgical devices market. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.

Furthermore, in June 2026, the International Diabetes Federation reported that approximately 589 million adults were living with diabetes globally, including more than 90% with type 2 diabetes. This number is projected to reach 853 million by 2050. The growing diabetic population is expected to increase demand for retinal screening, fundus cameras, optical coherence tomography systems, and devices used to diagnose and treat diabetic eye complications. (Source: International Diabetes Federation)

Global Ophthalmology Diagnostics and Surgical Devices Market: Restraints

Lower number of ophthalmologists in emerging economies is expected to hinder growth of the market. For instance, according to the study, “Estimated number of ophthalmologists worldwide (International Council of Ophthalmology update): will we meet the needs?” published in March 2020, in 2015, the ratio of ophthalmologists per million population for low-income countries was 3.7 compared to 76.2 for high-income countries.

Key Takeaways

The global ophthalmology diagnostics and surgical devices market was valued at US$ 40,381.6 Mn in 2019 and is forecast to reach a value of US$ 67,449.1 Mn by 2027 at a CAGR of 6.6% between 2020 and 2027. Major factor driving the growth of global ophthalmology diagnostics and surgical devices market during the forecast period include increasing ophthalmic diseases, and increasing geriatric population.

Vision care held dominant position in the global ophthalmology diagnostics and surgical devices market in 2019, accounting for 70.2% share in terms of value, followed by Surgical and Diagnostic, respectively. Vision care products include eyeglasses, and lenses which are easy to use, and adds to aesthetic as well which is expected to support growth of the market.

Market Trends

• Integration of Advanced Visualization and Intraoperative OCT

Ophthalmic surgery is increasingly adopting digital visualization, high-resolution imaging, and intraoperative optical coherence tomography to support precise, image-guided procedures. For instance, in February 2026, China’s National Medical Products Administration approved the ZEISS ARTEVO 750 and ARTEVO 850 ophthalmic surgical microscopes. These systems offer enhanced resolution, intelligent RGB illumination, intraoperative OCT, and integrated cataract-surgery workflows, improving surgical visualization, efficiency, and safety.

• Rising Burden of Uncorrected Refractive Errors

The high prevalence of myopia, presbyopia, astigmatism, and other refractive errors is increasing the need for vision screening, autorefractors, corneal diagnostic systems, and refractive-surgery equipment. In February 2026, the World Health Organization stated that uncorrected refractive error remains the leading cause of vision impairment among children and adults. WHO also estimated that more than 800 million people have uncorrected near-vision impairment, while global myopia cases could reach 3.36 billion by 2030.

• Development of High-Speed Vitreoretinal Surgical Devices

Manufacturers are developing faster and more stable vitrectomy systems to improve control during complex retinal procedures. For instance, in May 2026, Bausch + Lomb launched the Bi-Blade+ dual-port vitrectomy cutter in Europe for use with the Stellaris Elite system. The device operates at up to 25,000 cuts per minute and provides a 25% higher average flow rate, supporting efficient vitreous removal and improved intraocular pressure stability.

• Innovation in Intraocular Lenses for Improved Visual Outcomes

Demand is increasing for advanced intraocular lenses that provide extended vision ranges while minimizing glare, halos, and contrast loss. For instance, in March 2026, the U.S. FDA approved Johnson & Johnson’s TECNIS PureSee extended-depth-of-focus intraocular lens for cataract surgery. The lens provides improved intermediate vision while maintaining distance vision and contrast sensitivity comparable to an aspheric monofocal lens, expanding treatment options for cataract and presbyopia patients.

Global Ophthalmology Diagnostics and Surgical Devices Market: Competitive Landscape   

Major players operating in the global ophthalmology diagnostics and surgical devices market include, Abbott Medical Optics, Inc., Alcon Laboratories, Inc., Bausch & Lomb, Inc. (Valeant Pharmaceuticals), Carl Zeiss Meditec AG, CooperVision, Essilor International, Hoya Corporation, and Johnson & Johnson.

Global Ophthalmology Diagnostics and Surgical Devices Market: Key Developments

• In July 2026, Bausch + Lomb launched the EyeGility Inserter, a preloaded intraocular lens delivery system, in the United States. Designed for the enVista Aspire and Envy IOL portfolio, the device enables one-handed operation, balanced push force, and smooth lens insertion through a 2.4 mm incision. EyeGility aims to improve cataract surgery efficiency, reduce lens handling, and provide surgeons with a more convenient, reliable delivery workflow during routine implantation procedures. (Source: Bausch + Lomb)
• In April 2026, Alcon launched Clareon TruPlus enhanced-design monofocal and toric intraocular lenses in the U.S. at the ASCRS Annual Meeting. The lenses use Opti-Balance Technology to extend depth of focus while preserving high-quality distance vision. Bench data indicated improved intermediate visual acuity, higher distance image quality, and lower glare and halo compared with competing lenses. Alcon plans to introduce Clareon TruPlus in additional international markets globally later in 2026. (Source: Alcon)
• In April 2026, ZEISS Medical Technology announced new digital, artificial intelligence, and surgical innovations for ASCRS 2026 in Washington, D.C. Key developments included updated IOLMaster 700 and VERACITY Surgery Planner formulas, new DORC EVA NEXUS-compatible irrigation and aspiration instruments, and the U.S. commercial launch of VisioGen, a human-verified AI patient-engagement platform. ZEISS also showcased Collaborative Care and previewed CLINIC 360 to improve connected ophthalmic workflows and clinical coordination across practices. (Source: ZEISS Medical Technology)

Segmentation

• By Type
  • Diagnostic
    • Autorefractometers
    • Slit Lamps
    • Tonometers
    • Ophthalmoscopes
    • Fundus Cameras
    • Optical Coherence Tomography
    • Others
  • Surgical
    • Vitreoretinal Surgery
    • Cataract Surgery
    • Glaucoma Surgery
    • Refractive Surgery
  • Vision Care
    • Contact Lens
    • Spectacles Lenses
• By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa